Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06582017
Title Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Nammi Therapeutics Inc
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
University of Southern California NOT_YET_RECRUITING Los Angeles California 90033 United States Details
Cedars-Sanai Medical Center - Samuel Oschin Comprehensive Cancer NOT_YET_RECRUITING Los Angeles California 90048 United States Details
Hoag Memorial Hospital Presbyterian NOT_YET_RECRUITING Newport California 92663 United States Details
Sarah Cannon Research Institute - Denver DDU NOT_YET_RECRUITING Denver Colorado 80218 United States Details
Emory University - Winship Cancer Institute NOT_YET_RECRUITING Atlanta Georgia 30322 United States Details
New York Cancer & Blood Specialists NOT_YET_RECRUITING New York New York 11967 United States Details
University of Rochester - Wilmot Cancer Institute NOT_YET_RECRUITING Rochester New York 14642 United States Details
START San Antonio RECRUITING San Antonio Texas 78229 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field